{"count": 20, "results": [{"_id": "36075464", "pmid": 36075464, "title": "A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus.", "journal": "Diabetes Res Clin Pract", "authors": ["Xu L", "Wang W", "Song W"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.diabres.2022.110073", "meta_date_publication": "2022 Sep", "meta_volume": "191", "meta_issue": "", "meta_pages": "110073", "score": 50257.26, "text_hl": "A combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ improve cardiovascular @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@and cerebrovascular@@@ risk factors in individuals with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type 1 diabetes mellitus@@@.", "citations": {"NLM": "Xu L, Wang W, Song W. A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2022 Sep;191():110073. PMID: 36075464", "BibTeX": "@article{36075464, title={A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus.}, author={Xu L and Wang W and Song W}, journal={Diabetes Res Clin Pract}, volume={191}, pages={110073}}"}}, {"_id": "37567440", "pmid": 37567440, "title": "Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review.", "journal": "Transl Res", "authors": ["Geng Y", "Wang Z", "Xu X", "Sun X", "Dong X", "Luo Y", "Sun X"], "date": "2023-08-09T00:00:00Z", "doi": "10.1016/j.trsl.2023.08.001", "meta_date_publication": "2023 Aug 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.457, "text_hl": "Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: a systematic review.", "citations": {"NLM": "Geng Y, Wang Z, Xu X, Sun X, Dong X, Luo Y, Sun X. Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review. Transl Res. 2023 Aug 9;():. PMID: 37567440", "BibTeX": "@article{37567440, title={Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review.}, author={Geng Y and Wang Z and Xu X and Sun X and Dong X and Luo Y and Sun X}, journal={Transl Res}}"}}, {"_id": "33716063", "pmid": 33716063, "title": "Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.", "journal": "Life Sci", "authors": ["Sharma S", "Nozohouri S", "Vaidya B", "Abbruscato T"], "date": "2021-06-01T00:00:00Z", "doi": "10.1016/j.lfs.2021.119343", "meta_date_publication": "2021 Jun 1", "meta_volume": "274", "meta_issue": "", "meta_pages": "119343", "score": 50250.21, "text_hl": "Additionally, numerous studies have illustrated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s role in @DISEASE_Cerebral_Infarction @DISEASE_MESH:D002544 @@@ischemic stroke@@@, a @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disorder@@@ in which the NVU becomes dysfunctional which can lead to permanent life-threatening disabilities. ", "citations": {"NLM": "Sharma S, Nozohouri S, Vaidya B, Abbruscato T. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke. Life Sci. 2021 Jun 1;274():119343. PMID: 33716063", "BibTeX": "@article{33716063, title={Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.}, author={Sharma S and Nozohouri S and Vaidya B and Abbruscato T}, journal={Life Sci}, volume={274}, pages={119343}}"}}, {"_id": "37901890", "pmid": 37901890, "pmcid": "PMC10604500", "title": "Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions", "journal": "Clin Med Insights Endocrinol Diabetes", "authors": ["Khadilkar A", "Oza C", "Mondkar SA"], "date": "2023-10-26T00:00:00Z", "doi": "10.1177/11795514231206730", "meta_date_publication": "2023", "meta_volume": "16", "meta_issue": "", "meta_pages": "11795514231206730", "score": 50249.832, "text_hl": "Thus, although the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on glycemic control are variable, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ holds a promising role in having a cardioprotective effect as evidenced from its beneficial effects on @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profile and markers of early @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@. ", "citations": {"NLM": "Khadilkar A, Oza C, Mondkar SA. Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions Clin Med Insights Endocrinol Diabetes. 2023;16():11795514231206730. PMID: 37901890", "BibTeX": "@article{37901890, title={Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions}, author={Khadilkar A and Oza C and Mondkar SA}, journal={Clin Med Insights Endocrinol Diabetes}, volume={16}, pages={11795514231206730}}"}}, {"_id": "34209135", "pmid": 34209135, "pmcid": "PMC8268757", "title": "Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells", "journal": "Int J Mol Sci", "authors": ["Hansel C", "Barr S", "Schemann AV", "Lauber K", "Hess J", "Unger K", "Zitzelsberger H", "Jendrossek V", "Klein D"], "date": "2021-06-30T00:00:00Z", "doi": "10.3390/ijms22137064", "meta_date_publication": "2021 Jun 30", "meta_volume": "22", "meta_issue": "13", "meta_pages": "", "score": 50248.227, "text_hl": "...2.1. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment Prevents Radiation-Induced Senescence of Bronchial-Alveolar Epithelial Cells and Associated @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@Vascular Dysfunction@@@", "citations": {"NLM": "Hansel C, Barr S, Schemann AV, Lauber K, Hess J, Unger K, Zitzelsberger H, Jendrossek V, Klein D. Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells Int J Mol Sci. 2021 Jun 30;22(13):. PMID: 34209135", "BibTeX": "@article{34209135, title={Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells}, author={Hansel C and Barr S and Schemann AV and Lauber K and Hess J and Unger K and Zitzelsberger H and Jendrossek V and Klein D}, journal={Int J Mol Sci}, volume={22}, number={13}}"}}, {"_id": "40123939", "pmid": 40123939, "title": "Metabolic disorder of nutrients-an emerging field in the pathogenesis of preeclampsia.", "journal": "Front Nutr", "authors": ["Li S", "Zhu J", "Zhao Y", "An P", "Zhao H", "Xiong Y"], "date": "2025-03-07T00:00:00Z", "doi": "10.3389/fnut.2025.1560610", "meta_date_publication": "2025", "meta_volume": "12", "meta_issue": "", "meta_pages": "1560610", "score": 50235.73, "text_hl": "Emerging therapies, such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, demonstrate potential in targeting these pathways for prevention and treatment. ", "citations": {"NLM": "Li S, Zhu J, Zhao Y, An P, Zhao H, Xiong Y. Metabolic disorder of nutrients-an emerging field in the pathogenesis of preeclampsia. Front Nutr. 2025;12():1560610. PMID: 40123939", "BibTeX": "@article{40123939, title={Metabolic disorder of nutrients-an emerging field in the pathogenesis of preeclampsia.}, author={Li S and Zhu J and Zhao Y and An P and Zhao H and Xiong Y}, journal={Front Nutr}, volume={12}, pages={1560610}}"}}, {"_id": "36945734", "pmid": 36945734, "title": "Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.", "journal": "Diabetes Obes Metab", "authors": ["McGuire DK", "Busui RP", "Deanfield J", "Inzucchi SE", "Mann JFE", "Marx N", "Mulvagh SL", "Poulter N", "Engelmann MDM", "Hovingh GK", "Ripa MS", "Gislum M", "Brown-Frandsen K", "Buse JB"], "date": "2023-03-21T00:00:00Z", "doi": "10.1111/dom.15058", "meta_date_publication": "2023 Mar 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50231.152, "text_hl": "At randomization, 70.7% of participants had CAD, 42.3% had @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@CKD@@@, 21.1% had @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@ and 15.7% had symptomatic PAD (categories not mutually exclusive). ", "citations": {"NLM": "McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter N, Engelmann MDM, Hovingh GK, Ripa MS, Gislum M, Brown-Frandsen K, Buse JB. Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial. Diabetes Obes Metab. 2023 Mar 21;():. PMID: 36945734", "BibTeX": "@article{36945734, title={Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.}, author={McGuire DK and Busui RP and Deanfield J and Inzucchi SE and Mann JFE and Marx N and Mulvagh SL and Poulter N and Engelmann MDM and Hovingh GK and Ripa MS and Gislum M and Brown-Frandsen K and Buse JB}, journal={Diabetes Obes Metab}}"}}, {"_id": "27487294", "pmid": 27487294, "title": "Metformin and Angiogenesis in Cancer - Revisited.", "journal": "Oncology", "authors": ["Kannarkatt J", "Alkharabsheh O", "Tokala H", "Dimitrov NV"], "date": "2016-01-01T00:00:00Z", "doi": "10.1159/000448175", "meta_date_publication": "2016", "meta_volume": "91", "meta_issue": "4", "meta_pages": "179-184", "score": 50063.613, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has an interesting potential to treat @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ angiogenesis in conditions beyond @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Kannarkatt J, Alkharabsheh O, Tokala H, Dimitrov NV. Metformin and Angiogenesis in Cancer - Revisited. Oncology. 2016;91(4):179-184. PMID: 27487294", "BibTeX": "@article{27487294, title={Metformin and Angiogenesis in Cancer - Revisited.}, author={Kannarkatt J and Alkharabsheh O and Tokala H and Dimitrov NV}, journal={Oncology}, volume={91}, number={4}, pages={179-184}}"}}, {"_id": "24521306", "pmid": 24521306, "title": "Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats.", "journal": "Clin Sci (Lond)", "authors": ["Oliveira PW", "de Sousa GJ", "Caliman IF", "Lamas AZ", "Santos de Medeiros AR", "de Andrade TU", "de Abreu GR", "de Figueiredo SG", "Bissoli NS"], "date": "2014-08-01T00:00:00Z", "doi": "10.1042/CS20130553", "meta_date_publication": "2014 Aug", "meta_volume": "127", "meta_issue": "4", "meta_pages": "265-75", "score": 50062.887, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates ovariectomy-induced @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@ in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ Wistar @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Oliveira PW, de Sousa GJ, Caliman IF, Lamas AZ, Santos de Medeiros AR, de Andrade TU, de Abreu GR, de Figueiredo SG, Bissoli NS. Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats. Clin Sci (Lond). 2014 Aug;127(4):265-75. PMID: 24521306", "BibTeX": "@article{24521306, title={Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats.}, author={Oliveira PW and de Sousa GJ and Caliman IF and Lamas AZ and Santos de Medeiros AR and de Andrade TU and de Abreu GR and de Figueiredo SG and Bissoli NS}, journal={Clin Sci (Lond)}, volume={127}, number={4}, pages={265-75}}"}}, {"_id": "28212524", "pmid": 28212524, "pmcid": "PMC5312505", "title": "Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity", "journal": "Redox Biol", "authors": ["Prasad S", "Sajja RK", "Kaisar MA", "Park JH", "Villalba H", "Liles T", "Abbruscato T", "Cucullo L"], "date": "2017-08-01T00:00:00Z", "doi": "10.1016/j.redox.2017.02.007", "meta_date_publication": "2017 Aug", "meta_volume": "12", "meta_issue": "", "meta_pages": "58-69", "score": 50062.75, "text_hl": "Role of @GENE_NFE2L2 @GENE_4780 @@@Nrf2@@@ and protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ against @SPECIES_4097 @@@tobacco@@@ smoke-induced @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular toxicity@@@", "citations": {"NLM": "Prasad S, Sajja RK, Kaisar MA, Park JH, Villalba H, Liles T, Abbruscato T, Cucullo L. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity Redox Biol. 2017 Aug;12():58-69. PMID: 28212524", "BibTeX": "@article{28212524, title={Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity}, author={Prasad S and Sajja RK and Kaisar MA and Park JH and Villalba H and Liles T and Abbruscato T and Cucullo L}, journal={Redox Biol}, volume={12}, pages={58-69}}"}}]}